{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T04:19:16Z","timestamp":1741925956369,"version":"3.38.0"},"reference-count":18,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Liver Journal"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:p> Background: There is little research focused on women living with the hepatitis C virus (HCV). We evaluated the knowledge, opinions, and concerns of women living with HCV of child-bearing potential. We specifically focused on pregnancy-related and child rearing issues. Methods: Fifteen women aged 29 to 45 seen at The Ottawa Hospital Viral Hepatitis Program between July 2017 and June 2018 consented and completed a questionnaire. Eighty percent were born in Canada. The average duration of infection was 7.2 years. Results: The majority (67%\u201393%) of respondents reported health concerns, fear of stigma, and shame related to their HCV diagnoses. Most (80%) feared transmitting HCV to their partner. Women are more willing to seek a partner and\/or have children if they are cured of HCV. HCV-specific knowledge\u2014as it pertains to transmission risk and direct-acting antiviral (DAA) safety during pregnancy and child rearing\u2014was suboptimal and did not correlate with education level. All participants expressed a high degree of desire to receive DAA therapy. Conclusions: Better strategies to increase HCV-specific knowledge in women of child-bearing potential are required. Efforts to increase screening and treatment access in this population are warranted. <\/jats:p>","DOI":"10.3138\/canlivj-2019-0028","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T19:13:46Z","timestamp":1583176426000},"page":"294-299","source":"Crossref","is-referenced-by-count":2,"title":["An evaluation of knowledge and concerns in women of child-bearing potential living with chronic hepatitis C infection"],"prefix":"10.3138","volume":"3","author":[{"given":"Holly","family":"Hatashita","sequence":"first","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis","family":"Cooper","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","reference":[{"issue":"3","key":"r1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.mcna.2015.01.009","volume":"99","author":"Beste LA","year":"2015","journal-title":"Med Clin North Am"},{"key":"r2","unstructured":"2.Remis RS. Modelling the incidence and prevalence of hepatitis C infection and its sequelae in Canada, 2007. Ottawa: Public Health Agency of Canada; 2007. https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/sti-its-surv-epi\/model\/pdf\/model07-eng.pdf (Accessed February 5, 2020)."},{"issue":"4","key":"r3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7748\/ns.19.4.35.s62","volume":"19","author":"Grundy G","year":"2004","journal-title":"Nurs Stand"},{"issue":"6","key":"r4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","volume":"59","author":"Benova L","year":"2014","journal-title":"Clin Infect Dis"},{"key":"r5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejogrb.2015.09.009","volume":"194","author":"Garcia-Tejedor A","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"r6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1753495X17708093","volume":"10","author":"Post JJ.","year":"2017","journal-title":"Obstet Med"},{"issue":"6","key":"r7","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/apt.13514","volume":"43","author":"Banerjee D","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"r8","unstructured":"8.Ontario Ministry of Health and Long-Term Care. Ontario Drug Benefit Formulary\/Comparative Drug Index. Edition 42. Toronto: Government of Ontario; 2017 [updated 2017 Feb 28]. Available from: http:\/\/www.health.gov.on.ca\/en\/pro\/programs\/drugs\/formulary42\/summary_edition42_20170228.pdf."},{"issue":"12","key":"r9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4254\/wjh.v8.i12.557","volume":"8","author":"Spera AM","year":"2016","journal-title":"World J Hepatol"},{"issue":"4","key":"r10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1300\/J013v39n04_07","volume":"39","author":"Crockett B","year":"2004","journal-title":"Women Health"},{"issue":"10","key":"r11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/jvh.12095","volume":"20","author":"Chen EY","year":"2013","journal-title":"J Viral Hepat"},{"issue":"4","key":"r12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1467-842X.1998.tb01423.x","volume":"22","author":"Sladden TJ","year":"1998","journal-title":"Aust N Z J Public Health"},{"issue":"2","key":"r13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1071\/PY11127","volume":"19","author":"Olsen A","year":"2013","journal-title":"Aust J Prim Health"},{"issue":"2","key":"r14","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1097\/QAI.0000000000000659","volume":"69","author":"Iversen J","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"r15","unstructured":"15.United Nations Office on Drugs and Crime (UNODC). Women who inject drugs and HIV: addressing specific needs. Vienna: UNODC; 2014. Available from: https:\/\/www.unodc.org\/documents\/hiv-aids\/publications\/WOMEN_POLICY_BRIEF2014.pdf."},{"key":"r16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugpo.2019.05.013","volume":"72","author":"Rojas Rojas T","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"7","key":"r17","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1440-1746.2003.03077.x","volume":"18","author":"Gifford SM","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"r18","doi-asserted-by":"crossref","first-page":"E198","DOI":"10.1503\/cmaj.140545","volume":"187","author":"Burns KE","year":"2015","journal-title":"CMAJ"}],"container-title":["Canadian Liver Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/canlivj-2019-0028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T12:38:05Z","timestamp":1741869485000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/canlivj-2019-0028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.3138\/canlivj-2019-0028"],"URL":"https:\/\/doi.org\/10.3138\/canlivj-2019-0028","relation":{},"ISSN":["2561-4444","2561-4444"],"issn-type":[{"type":"print","value":"2561-4444"},{"type":"electronic","value":"2561-4444"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}